Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: São Paulo Advanced School of Comparative Oncology: Abstracts

Open Access Open Badges Poster presentation

Chemical carcinogenesis by 7,12-dimethylbenzanthracene in balb/c mice

Marcello V Tedardi1*, Krishna D Oliveira1, Gabriela U Avanzo1, Marcelo MM Rangel1, José L Avanzo1, Heidge Fukumasu2, Kurapati VK Rao1, Idércio Luiz Sinhorini1 and Maria Lúcia Z Dagli1

Author Affiliations

1 Department of Pathology, School of Veterinary Medicine and Animal Science, University of Sao Paulo, Sao Paulo, SP, Brazil

2 Department of Pathology, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga, SP, Brazil

For all author emails, please log on.

BMC Proceedings 2013, 7(Suppl 2):P46  doi:10.1186/1753-6561-7-S2-P46

The electronic version of this article is the complete one and can be found online at:

Published:4 April 2013

© 2013 Tedardi et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Experimental models of carcinogenesis have been used in cancer researches, mainly with radiation or chemicals like 7,12-dimethylbenzanthracene (DMBA) which is a polycyclic aromatic hydrocarbon. This chemical group contains the majority of carcinogens and requires biotransformation in the liver and mammary gland.

Patients and methods

The carcinogen DMBA was administered by gavage to 70 Balb/c female mice, diluted in corn oil, at hebdomadary doses of 1 mg per animal for 1, 3, 6 or 9 weeks. Others 20 animals were used in the control group, who received only corn oil administration. Animals were weighed and monitored weekly until death, remaining animals were euthanized at age of 53 weeks. At necropsy, representative fragments of tumors were harvested, routinely processed for microscopy and classified agreeing with International Agency for Research on Cancer (IARC).


Control group hadn’t any behavioral or physical alterations. Tumors started being observed after 10 weeks of the beginning of DMBA protocol and the animals that received doses of 1 and 3mg survived more than 6 and 9mg groups. Were detected tumors in 67,14% of animals from DMBA groups and mammary tumors were the most common, counting 22 of them (31.43%). Cancer developed also in other primary sites: lungs (17.14%), lymphoid tissues (11,43%), stomach (7.14%) and skin (1.43%). Breast and gastric cancer were more frequents at higher doses and lung cancer in lower ones.


It’s an effective and flexible carcinogenesis model that can be useful for studies for multiple cancers, especially in breast, gastric, lymphoid and lungs.

Financial support



The first author is presenting the abstract on behalf of the study group.